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We report the pattern of transgene expression across brain regions after intrathecal
delivery of adeno-associated virus serotype 5 (AAV5). Labeling in hindbrain appeared to
be primarily neuronal, and was detected in sensory nuclei of medulla, pontine nuclei, and
all layers of cerebellar cortex. Expression in midbrain was minimal, and generally limited
to isolated neurons and astrocytes in the cerebral peduncles. GFP immunoreactivity (-ir)
in thalamus was most prominent in medial geniculate nucleus, and otherwise limited
to posterior nuclei of the dorsal and lateral margins. Labeling was also observed in
neurons and astrocytes of the hippocampal formation and amygdaloid complex. In the
hippocampal formation, GFP-ir was found in neuronal cell bodies of the rostral ventral
portion, but was largely restricted to fiber-like staining in the molecular layer of dentate
gyrus and stratum lacunosum-moleculare of the rostral dorsal region. GFP-ir was seen in
neurons and astroglia throughout caudal cortex, whereas in rostral regions of neocortex
it was limited to isolated neurons and non-neuronal cells. Labeling was also present in
olfactory bulb. These results demonstrate that intrathecal delivery of AAV5 vector leads to
transgene expression in discrete CNS regions throughout the rostro-caudal extent of the
neuraxis. A caudal-to-rostral gradient of decreasing GFP-ir was present in choroid plexus
and Purkinje cells, suggesting that spread of virus through cerebrospinal fluid plays a role
in the resulting transduction pattern. Other factors contributing to the observed expression
pattern likely include variations in cell-surface receptors and inter-parenchymal space.
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INTRODUCTION
In recent years a growing body of evidence has indicated that
adeno-associated virus (AAV) is a useful vector for delivery of
therapeutic genes to the central nervous system (CNS). Direct
injection of AAV vectors into a specific CNS nucleus can result
in a high level of gene expression in that nucleus, as well as phys-
ically adjacent and functionally connected areas (Fu et al., 2002;
Ciesielska et al., 2011; White et al., 2011). However, this method
carries the drawback of tissue damage that is potentially both
detrimental and irreparable. Therefore, alternative approaches
for CNS delivery of AAV vectors, such as delivery to the cere-
brospinal fluid (CSF), are necessary for translational development
of AAV-mediated gene therapy.
Delivery to the CSF can be achieved in a variety of ways includ-
ing injection into the cerebral ventricles, the posterior cistern, and
the spinal intrathecal space. Acute injection of AAV vectors into
the posterior cistern, without the use of any method to enhance
distribution, has resulted in a relatively limited pattern of gene
expression that appears analogous to that seen with ventricular
injection (Fu et al., 2003). On the other hand,methods to improve
vector distribution upon cisternal administration, such as pre-
treatment with mannitol delivered intravenously or removal of
some CSF followed by a large injection volume, have shown the
potential for an enhanced pattern of gene expression spanning
several CNS regions (Fu et al., 2003; Iwamoto et al., 2009).
Surgical access to the posterior cistern has also been used
for intrathecal catheter placement with the goal of delivery of
AAV6 or AAV8 directed at the lumbar spinal level (Storek et al.,
2008; Towne et al., 2009). Substantial transduction of lumbar dor-
sal root ganglion (DRG) neurons was achieved in both of these
studies. Additionally, Towne et al. (2009) observed transduction
in cervical DRG and several areas of the brain. An alternative
method for delivery to the lumbar intrathecal space is direct
lumbar puncture, which is minimally invasive, does not require
anesthesia, presents negligible risk for tissue damage, and has long
been used both experimentally and clinically.
We recently demonstrated transduction of DRG neurons
following delivery of AAV5 or AAV8 by direct lumbar punc-
ture with an intravenous mannitol pretreatment (Vulchanova
et al., 2010). The goal of the current study was to determine the
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extent of expression in the CNS after lumbar puncture delivery
of AAV5.
MATERIALS AND METHODS
AAV VECTOR AND PACKAGING
AAV vector TRUF11, containing a CBA- (cytomegalovirus
enhancer with a chicken β-actin promoter) regulated GFP
sequence, has been previously described (Kaemmerer et al., 2000).
Packaging using AAV5 serotype capsid was carried out at the
University of Florida Vector Core Lab of the Gene Therapy Center
(Gainesville, Florida) as previously described (Zolotukhin et al.,
2002).
ANIMALS
Experimental subjects were 20–25 g adult male C57BL/6 mice
(Harlan, Madison, WI). All experiments were reviewed and
Table 1 | Relative abundance of GFP-ir in brain after intrathecal
AAV5-GFP delivery with an intravenous mannitol pretreatment
(evaluated in 8 animals from two separate experiments; each
structure was observed in at least 3 different sections).
Brain area Neuronal Neuronal Non-neuronal
somata fibers cells
Gracile/Cuneate n. − + + + −
Spinal Trigeminal n. and tract + ++ −
NTS, Solitary tract, and AP ++ ++ −
Vestibular/Cochlear n. + + −
Facial n. + + −
Cerebellum ++ ++ −
4th Ventricle Choroid Plexus − − + + ++
Pons ++ ++ −
Inferior Colliculus + + −
Superior Colliculus + + −
Cerebral Peduncles − − ++
Medial Geniculate n. ++ ++ −
LGN and Posterior Thalamic n. + ++ −
Hypothalamus + + −
3rd Ventricle Choroid Plexus − − + + +
Subiculum + + + ++ ++
Entorhinal Ctx. + + + ++ ++
Caudal visual & Retrosplenial Ctx. ++ ++ ++
Rostral visual & Retrosplenial Ctx. + + +
Rostral−Ventral Hippocampal Form. + + + ++ +
Rostral−Dorsal Hippocampal Form. − + + + −
Amygdala ++ + −
Lateral Ventricles Choroid Plexus − − + + +
Cingulate, Motor & Sensory Ctx. + + +
Olfactory bulb ++ ++ ++
Definitions of relative abundance: −, no GFP labeling observed; +, isolated cells;
++, multiple labeled cells observed in close proximity to one another; + + +,
GFP-ir at least as prevalent as ++ throughout the structure, with some areas
showing markedly increased GFP-ir; + + ++ = a substantial fraction of cells
throughout the entire structure showed GFP-ir. Abbreviations: n, nucleus; NTS,
nucleus of the solitary tract; AP, area postrema; LGN, lateral geniculate nucleus;
Ctx, cortex.
approved by the Institutional Animal Care and Use Committee
(IACUC) of the University of Minnesota.
INJECTIONS
Subjects were injected via the tail vein with 25% mannitol solu-
tion (200μL) 20min prior to intrathecal or intravenous injection
of the viral construct. For intrathecal delivery, the AAV construct
was delivered by direct lumbar puncture in awake mice by an
experimenter (KFK) with extensive experience in this method
of drug delivery (Hylden and Wilcox, 1980). In a minor mod-
ification to the protocol, the needle (30-gauge, 0.5-inch) was
connected to a length of PE10 tubing, which was then connected
to a second needle that was attached to a 50μl Luer-hubHamilton
syringe. Ten microliters containing ∼1011 vector genomes was
injected intrathecally. The injection was administered by gently
gripping the iliac crest of the rodent and inserting the needle
(bevel side up) at about a 45◦ angle centered between the hip-
bones. A reflexive flick of the tail indicated puncture of the dura.
For intravenous AAV5 injections, the same total dose of vector
(∼1011 vector genomes) was diluted 10-fold in sterile saline to a
final volume of 100μL. Following injection of AAV, the animals
were returned to the vivarium where they remained for 6 weeks,
until the time of transcardial perfusion, fixation, and extraction
of fixed brain tissue for immunohistochemical analysis.
IMMUNOHISTOCHEMISTRY
All animals were sacrificed by perfusion fixation as previously
described (Vulchanova et al., 1998). Briefly, animals were isoflu-
rane anesthetized via nosecone inhalation and perfused with a
solution of calcium-free tyrodes solution (in mM:NaCl 116, KCl
5.4, MgCl2·6H20 1.6, MgSO4·7H2O 0.4, NaH2PO4 1.4, glucose
5.6, and NaHCO3 26) followed by fixative (4% paraformalde-
hyde and 0.2% picric acid in 0.1M phosphate buffer, pH 6.9)
followed by 10% sucrose in PBS. Brain was removed and incu-
bated in 10% sucrose overnight at 4◦C. Sections were cut at
14μm thickness and thawmounted onto gel-coated slides. Tissue
sections were incubated for 1 h at room temperature in dilu-
ent (PBS containing 0.3% Triton, 1% BSA, 1% normal don-
key serum) and then incubated overnight at 4◦C in primary
antisera diluted in the same solution. Primary antibodies used
FIGURE 1 | GFP-ir fibers in somatosensory nuclei of the medulla. (A)
Low-magnification image showing the pattern of NeuN-ir in this tissue
section (approximately −7.3mm Bregma). (B) GFP-ir in the gracile (∗) and
cuneate (#) nuclei.
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were: rabbit anti-GFP, 1:500 (Invitrogen; Eugene, OR), mouse
anti-NeuN, 1:500 (Chemicon; Temecula, CA), mouse anti-GFAP,
1:400 (Sigma; St. Louis, MO), and mouse anti-calbindin, 1:1000
(Sigma; St. Louis, MO), rat anti-CD68, 1:100 (AbD Serotec,
Oxford, UK). After rinsing with PBS, sections were incubated
1 h at room temperature with appropriate combinations of Cy2-
, Cy3-, and Cy5- (1:300) conjugated secondary antisera (Jackson
ImmunoResearch, West Grove, CA). Sections were rinsed again,
and in some cases, were also incubated with DAPI nucleic acid
stain for 3–5min, 300 nM (Invitrogen; Eugene, OR). Following
the final rinses, sections were cover-slipped using glycerol and
PBS containing 0.1% p-phenylenediamine (Sigma).
MICROSCOPY
Anatomical analysis was based on the “The Mouse Brain In
Stereotaxic Coordinates,” Second Edition (Paxinos and Franklin,
2001). Images for Figures 3 and 10 were collected at a resolution
of 1600 by 1200 pixels on an Olympus BX60 fluorescence micro-
scope with a Spot Insight camera and Spot image acquisition
software. Images in Figures 4E,F, 7 and 8B were collected with an
Olympus BX50FA fluorescence microscope equipped with a CCD
camera. All other images were collected on an Olympus Fluoview
1000 confocal microscope with associated software at a resolu-
tion of 512 by 512 pixels. Images were processed for contrast,
brightness, and color in Adobe Photoshop.
QUANTIFICATION
For quantification of number of fourth ventricle choroid plexus
cells transduced, 3 sections per ventricle, spaced at least 100μm
apart were counted for each of 4 animals. The total number of
choroid plexus cells in each section was determined by counting
FIGURE 3 | GFP-ir in Purkinje cells of the cerebellum. (A) GFP-ir,
showing one labeled cell. (B) Calbindin-ir illustrating the difference in
morphology between the molecular, Purkinje, and granule cell layers of the
cerebellum. (C) Overlay of images in (A) and (B) illustrating that this
GFP-positive neuron is a Purkinje cell. (D) A graph showing the fraction of
GFP-positive Purkinje cells found at different distances from Bregma
indicates a trend toward decreasing transduction of Purkinje cells in more
rostral portions of cerebellum. Only GFP-positive Purkinje cells were
counted. The graph represents counted cells for each range of distances
from Bregma as percent of all GFP-positive Purkinje cells (78 total cells
counted). There was no significant difference in the number of GFP-positive
Purkinje cells found in each range of distances from Bregma (One-Way
ANOVA, P > 0.05, n = 4).
FIGURE 2 | GFP-ir in sensory nuclei of the medulla. (A) Low-magnification
image showing the pattern of NeuN-ir in this tissue section (approximately
−6.8mm Bregma). Colored inset boxes show the locations of the images in
(B–D). (B) A GFP-positive neuron in the nucleus of the solitary tract. (C)
GFP-ir in the external cuneate nucleus. (D) GFP-ir in the spinal trigeminal tract
(center diagonal) and lateral to that in the inferior cerebellar peduncle (right).
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nuclei within each ventricle identified by DAPI stain. Choroid
plexus cells immuno-positive for GFP were identified by overlay-
ing images of DAPI fluorescence and GFP-ir, and counting nuclei
that were surrounded by GFP-ir. Two independent observers per-
formed counts yielding results that consistently varied by less
than six percent per section. Results are graphed as percent of
counted choroid plexus cells for a given ventricle that displayed
GFP immunoreactivity (-ir).
For quantification of transduced Purkinje cells, at least 6 sec-
tions spaced at least 70μm apart were counted for each of the
4 animals. Only Purkinje cell bodies that showed GFP-ir were
counted, and were identified by co-labeling with calbindin-ir.
Results are graphed as the percent of counted cells that were
located in a given range of distances from Bregma.
STATISTICS
For quantification of choroid plexus cells and Purkinje cells, data
are represented as mean ± standard error of the mean. Data were
analyzed using one-way analysis of variance (ANOVA) followed
by a Bonferroni post-hoc test. Data analysis, and production of
graphs, was done with GraphPad Prism 4.0 software.
RESULTS
Six weeks after intrathecal administration of AAV5, GFP
expression was observed in discrete areas of the central nervous
system (CNS), while intravenous delivery of an equivalent total
dose of vector resulted in no detectable expression in the CNS.
The figures illustrating localization of GFP-ir are presented in a
caudal-to-rostral sequence and are referenced as necessary for the
descriptions of anatomical regions, which may be represented on
more than one figure. The relative abundance of GFP-positive
cells in different structures is shown in Table 1. Throughout the
CNS we observed GFP-positive neurons and astrocytes, as evi-
denced by colocalization with NeuN and GFAP, respectively. To
address the immune status of the brains of AAV treated ani-
mals we performed labeling for the microglial marker CD68, and
found no qualitative difference in CD68 labeling between naïve
and AAV5 treated animals (data not shown).
In the medulla, (as seen in Figures 1A, 2A) GFP-immunore-
activity (-ir) was found primarily in dorsal sensory, and cra-
nial nerve nuclei. In the gracile, cuneate and external cuneate
nuclei (Figures 1, 2C), as well as in the spinal trigeminal tract
(Figure 2D), labeling was observed in neuronal fibers, but was
absent from cell bodies. Fiber labeling in the gracile, cuneate, and
external cuneate nuclei is likely to have originated from primary
sensory neurons in dorsal root ganglia (DRG), as supported by
our previously published observations of GFP-ir in nerve fibers
within the dorsal columns of spinal cord (Vulchanova et al.,
2010). In line with this observation, fibers in the spinal trigeminal
tract are likely to have originated from neurons in the trigeminal
ganglion. In vestibular nuclei and the solitary nuclear complex
(Figure 2B), GFP-ir was found in neuronal cell bodies as well as
fibers. GFP expression was also observed in cochlear and facial
nuclei, and the area postrema (not shown).
FIGURE 4 | GFP-ir in caudal cortex and midbrain. (A–D) Co-localization
of GFP with neuronal and astroglial markers in caudal cortex. (A) Low
magnification image of NeuN-ir and colored inset boxes illustrate the
locations of images in (B–D) (approximately −4.2mm Bregma). (B) GFP-ir
in cells across areas of primary visual cortex (v), retrosplenial cortex (rs),
and presubiculum (prs). (C) Co-localization of GFP-ir with GFAP-ir
illustrates that astrocytes are transduced, and can be distinguished by
their morphology. (D) GFP-ir in neurons of the subiculum as evidenced
by colocalization with NeuN-ir. (E,F) GFP-ir in isolated neurons in the
superior colliculus. Arrows indicate GFP-positive neurons.
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In cerebellum, GFP-ir was observed in Purkinje cells
(Figure 3), as well as cell bodies and fibers of the granular
cell layer (not shown). Quantification of GFP-ir Purkinje cells
co-labeled for calbindin showed a trend toward decreasing trans-
duction of Purkinje cells in caudal-to-rostral fashion (Figure 3D).
Although this trend did not reach significance, it supports the
hypothesis that vector is distributed partially via rostral move-
ment through CSF.
GFP expression was observed in several areas of the caudal cor-
tices including primary and secondary visual cortex, retrosplenial
cortex, presubiculum, parasubiculum, subiculum, and entorhinal
cortex. In these locations, GFP-ir was seen in both neurons and
astrocytes as evidenced by co-localization of GFP-ir with NeuN-
ir or GFAP-ir respectively (Figures 4A–D). GFP-ir in midbrain,
thalamus, and hypothalamus was predominantly limited to neu-
rons, with the exception of astrocytes in the cerebral peduncles. In
midbrain, GFP expression wasminimal and observed primarily in
isolated neurons within the intermediate gray matter of superior
colliculus (Figures 4E,F).
In the most caudal portions of the hippocampus, (as seen
in Figure 5A) GFP expression was found in granule cells of
the dentate gyrus (Figure 5B), as well as pyramidal cells of the
CA3 region (Figure 5C). The same tissue section shows GFP- ir
in neurons of the medial geniculate nucleus (Figures 5D,E) of
the thalamus, as well as in pontine nuclei (Figures 5F,G). The
most rostral sections of hippocampus (as seen in Figure 6A)
revealed many GFP-positive neuronal cell bodies only in the ven-
tral portions (Figure 6B), whereas the dorsal portions contained
primarily fiber-like staining in the molecular layer of the dentate
gyrus and the stratum lacunosum-moleculare of the hippocam-
pus proper (Figure 6E). Some GFP-expressing neurons were also
observed in the amygdaloid nuclear complex (Figure 6C). A few
neurons and some neuronal fibers were also observed in the
pretectal, lateral geniculate, and posterior nuclei of thalamus
(Figure 6E, dorsolateral surface of thalamus indicated by arrows).
Labeling of non-neuronal cells, possibly astrocytes based on cell
morphology similar to that shown in Figure 4C, in the cere-
bral peduncles is shown in Figures 6B,C (cp). In hypothalamus,
GFP-ir was limited to isolated neurons (Figure 7).
Evaluation of tissue sections in more rostral regions of neo-
cortex revealed that GFP expression became less prevalent with
labeling present only in isolated neurons and non-neuronal
cells, which appeared to be astrocytes based on morphology.
(Figure 8). GFP-ir was generally absent from striatum and min-
imal in surrounding neocortex. Sparse GFP-ir was seen in the
islands of Calleja, the olfactory tubercles, and more rostrally
in orbital cortex (not shown). In the olfactory bulbs expres-
sion of GFP was considerable, and was found in neurons and
FIGURE 5 | GFP-ir in the caudal thalamus, hippocampal formation,
and pons. (A) Low magnification image of NeuN-ir and colored inset
boxes illustrate the locations of images in B-G (approximately −3.0mm
Bregma). (B–G) Green shows GFP-ir, red shows NeuN-ir, and merged
images illustrate co-localization in yellow. (B) A GFP-positive neuron in
the granular layer of the dentate gyrus. (C) A GFP-positive neuron in
the pyramidal layer of hippocampus area CA3. (D) GFP-ir in the medial
geniculate nucleus (MGN) of the thalamus. (E) High magnification
image of the area outlined by the blue box in D, illustrating that
expression in the MGN is neuronal. (F) GFP expression in pontine
nuclei. (G) High magnification image of the area outlined by the blue
box in F, illustrating co-localization with NeuN-ir.
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FIGURE 6 | GFP-ir in the hippocampal formation, amygdala, and
thalamus. (A) Low magnification image of NeuN-ir and colored inset
boxes illustrate the locations of images in (B–D) (approximately −1.9mm
Bregma). (B) Substantial GFP-ir in neurons of the ventral dentate gyrus,
ventral hippocampus, and superior to those, astrocytes in the cerebral
peduncle (cp). (C) GFP expression in the amygdalohippocampal area, and
superior to that, astrocytes in the cerebral peduncle (cp). (D) GFP-ir in
the amygdaloid nuclear complex, and superior to that, in choroid plexus
of the lateral ventricle (arrow). (E) GFP-ir in the dorsal hippocampal
formation, and inferior and lateral to that (arrows), in thalamus including
portions of the lateral geniculate, and posterior nuclei. Note that GFP-ir in
the dorsal hippocampal formation appears restricted to fibers in the
molecular layer of the dentate gyrus and the stratum
lacunosum-moleculare of the hippocampus.
FIGURE 7 | GFP-ir in isolatedneurons inhypothalamus.Blue insets in (A,E,I)
show the location of the corresponding higher magnification images relative to
the third ventricle (3v) and the cerebral peduncle (cp). Green shows GFP-ir, red
shows NeuN-ir, and merged images illustrate co-localization in yellow. Neurons
within lateral hypothalamus are shown in (B–D) and (F–H). (J–L) show a neuron
in the supramammillary complex. All arrows indicate GFP-positive neurons.
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FIGURE 8 | GFP-ir in neocortex. Colocalization of GFP-ir (green) and NeuN-ir (red) in cingulate cortex (A, ∗ indicates the location of the median fissure) and
somatosensory cortex (B). All arrows indicate GFP-positive neurons.
non-neuronal cells with astrocytic morphology in the medial
portions of the glomerular, external plexiform, and mitral cell
layers (Figure 9).
GFP-ir was evident in the choroid plexus (Figure 10 – 4th
ventricle; Figure 6D, arrow – lateral ventricle), the structure that
produces and secretes cerebrospinal fluid (CSF). Quantification
of transduced choroid plexus cells throughout the ventricular
system revealed that expression in the fourth ventricle was signif-
icantly higher than in the third or lateral ventricles (Figure 10D).
This finding indicates that rostral movement through CSF from
the injection site is an important factor in vector distribution.
DISCUSSION
In this report we have demonstrated AAV5-mediated gene trans-
fer to the CNS using direct lumbar puncture intrathecal injection.
Although GFP labeling was present throughout the rostro-caudal
extent of the neuraxis, transgene expression was non-uniform and
restricted to discrete brain regions. We have considered several
factors that may influence the distribution of viral particles and
the observed pattern of AAV5 transduction in the CNS.
We observed a caudal-to-rostral gradient of GFP expression
within certain brain structures. For example, we found that a sig-
nificantly larger portion of fourth ventricle choroid plexus cells
express GFP relative to the third and lateral ventricles after AAV5.
Considering the closer proximity of the fourth ventricle to the
injection site, these results suggest that virus particles become
less concentrated as they move through CSF rostral to the spinal
column. Consistent with this observation, in cerebellum there
appears to be a caudal to rostral trend from higher to lower
number of GFP-expressing Purkinje cells.
The expression of vector genes or protein products in periph-
eral tissues suggests that intrathecally delivered viral vectors may
also be distributed through the vascular system. We have con-
sistently observed GFP expression in liver in our experiments
(not shown), which is in line with previous reports of lumbar
intrathecal AAV administration (Towne et al., 2009; Gray et al.,
2013). These observations raise the possibility that some of the
CNS expression observed may be the result of virus that has
been distributed through the circulatory system. To address this
hypothesis, we injected the same total dose of AAV5 that was
given intrathecally, but delivered it intravenously after mannitol
pretreatment. With this method we saw no detectable expression
in the CNS (not shown). These results suggest that the vector
does not regain access to the CNS after entering the peripheral
circulation following intrathecal delivery at the doses we have
used.
A remarkable finding that is not consistent with a simple
caudal-to-rostral distribution of virus particles through the CSF
is the relatively high (compared to other rostral forebrain regions)
level of GFP expression in the medial portion of the olfactory
bulb. Although the mechanism by which this level of expression
is achieved is unknown, other groups have reported similar find-
ings after injection of other AAV serotypes (AAV1 and AAV2)
into either the posterior cistern or the lumbar intrathecal space
(Fu et al., 2003; Watson et al., 2006; Iwamoto et al., 2009).
Considering the position of the olfactory bulb in a small recess
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FIGURE 9 | GFP-ir in the olfactory bulb. (A) Low magnification image showing NeuN-ir. (B) GFP-ir in neurons and astrocytes of the glomerular, external
plexiform, and mitral cell layers of the medial olfactory bulb.
FIGURE 10 | GFP expression in the choroid plexus. (A) GFP-ir in choroid
plexus of the 4th ventricle. (B) DAPI staining in the same section showing
cellular nuclei in the choroid plexus (center), cerebellum (top), and medulla
(bottom left and right). (C) Overlay of images in (A) and (B) showing a
substantial portion of the choroid plexus cells to be transduced. (D) Graph
illustrating that transduction of choroid plexus cells is significantly higher in
the 4th ventricle compared to the third and lateral ventricles. ∗Indicates
significance as determined by one-way ANOVA followed by Bonferroni
post-hoc analysis, (p < 0.001, n = 4). Across all animals and ventricles
35,071 nuclei were counted, 3708 of which were identified as GFP-positive.
at the rostral end of the skull, it is possible that in this pocketed
structure CSF flow may be restricted in a way that increases the
retention of virus particles. In fact, it is known that CSF is able to
drain along the olfactory nerve through the cribriform plate, and
that this drainage constitutes a major pathway for CSF absorption
in multiple species (Erlich et al., 1986; Williams and Blakemore,
1990; Kiwic et al., 1998;Mollanji et al., 2001). Significant CSF flow
toward the olfactory nervemay cause virus particles following this
current to get congested in the space near the olfactory bulb. An
alternative explanation for the observed expression in olfactory
bulb is that the cells may have migrated from the subventricu-
lar zone through the rostral migratory stream. We observed little
to no GFP-ir in the subventricular zone (not shown); however,
as tissue was examined 6 weeks after vector injection, we cannot
rule out the possibility that GFP-positive cells in olfactory bulb
may have been transduced in the subventricular zone prior to
migration through the rostral migratory stream.
Another brain region with a noteworthy expression pattern
that was non-uniform within the structure was the hippocam-
pal formation. GFP-positive cell bodies (primarily neuronal) were
found in the hippocampal formation, and were most prevalent in
the rostral-ventral region. Although GFP-ir was also present in
the rostral-dorsal hippocampal formation, labeling was primar-
ily neuropil-like, and rarely found in neuronal cell bodies. This
suggests that the fiber staining originates from neuronal cell bod-
ies in another location, most likely the entorhinal cortex, where
GFP-positive neurons were observed. It is unclear why neurons
in ventral hippocampus were transduced much more efficiently
that in dorsal hippocampus. One possible explanation is variation
in the level of expression of cell surface receptors for virus par-
ticles. For AAV5, there are two known receptors: α2,3 N-linked
sialic acid and platelet-derived growth factor receptor (PDGFR)
types alpha and beta (Walters et al., 2001; Di Pasquale et al.,
2003). There is currently no literature directly describing the pat-
tern of expression of α2,3 N-linked sialic acid in the mouse brain.
We have previously used lectin-histochemistry to investigate α2,3
N-linked sialic acid in DRG and observed diffuse staining with no
apparent relationship between labeling intensity and expression
of vector-delivered GFP (unpublished observations). For both
PDGFR alpha and beta, high expression levels have been reported
in CNS regions where AAV5 transduction was limited or absent in
our experiments, suggesting that PDGFR is not the limiting fac-
tor for transduction by AAV5 in the CNS (Fruttiger et al., 1999;
Ishii et al., 2006). Though we cannot make a direct link between
AAV5 receptor expression and our observed transduction pat-
tern, the dorsal and ventral hippocampus have been shown to
differ both in function and molecular expression (Fanselow and
Dong, 2010). Additionally, we have previously shown in dorsal
root ganglia that AAV5 differentially targets subpopulations of
DRG neurons that are defined by differences in molecular expres-
sion and function (Vulchanova et al., 2010). Our observations in
the hippocampal formation may also reflect AAV vector tropism
for specific cellular subpopulations.
One anatomical feature of the CNS that could explain dif-
ferences in expression across brain regions is parenchymal per-
meability due to differences in the structure of the pia mater.
Although it has been reported that the organization of the pia
mater varies substantially (Morse and Low, 1972), this variability
has not been examined systematically. Moreover, there is evidence
for the presence of fenestrations within the pia mater, which,
at least at the level of spinal cord, appear to be differentially
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distributed (Reina et al., 2004). Interestingly, the lack of fenestra-
tions at thoracic levels correlates with the reduced transduction
frequency at thoracic levels compared to lumbar and cervical lev-
els (Towne et al., 2009; Vulchanova et al., 2010), supporting the
idea that differential membrane permeability may influence the
distribution of viral vector delivered intrathecally.
In summary, the pattern of transduction in the CNS fol-
lowing intrathecal administration of an AAV vector with an
intravenous mannitol pretreatment appears to be the result of
several factors discussed above, including: rostral movement
through CSF, overall CSF flow, membrane permeability, and
expression of cell surface receptors for virus particles. The cur-
rent study has revealed that under these specific spinal drug
delivery conditions, discrete brain areas appear to be transduced
by AAV5.
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